The Advisory Committee on Immunization Practice (ACIP) recommends that all healthcare personnel (HCP) be vaccinated against influenza every year.
The DEA's Final Rule moving hydrocodone combination products (HCPs) from Schedule III to Schedule II will go into effect starting October 6, but physicians should be prepared for this change in advance to minimize disruptions in patient treatment plans.
When prescribing an antidepressant, clinicians should weigh the risks and benefits associated with SSRIs for patients at an increased risk of GI bleeding and consider other antidepressant classes.
Although studies have suggested that blood transfusions from Ebola virus survivors to infected individuals may help to treat or prevent infection, it is unknown if the antibodies in the plasma of survivors is sufficient to treat or prevent the disease.
For chronic pain patients being unsuccessfully treated with high-dose full-opioid agonists, switching to sublingual buprenorphine, can provide effective pain management and improve a patient's quality of life.
In order to help clinicians make informed decisions for patients suffering with allergic skin diseases, 24 recent publications on the treatment of atopic dermatitis were reviewed in a new article.
Migraines in midlife may be associated with increased odds of developing Parkinson's disease or other movement disorders in later years.
There is little evidence that testosterone replacement therapy effectively treats normally declining levels of the hormone in aging American males, a U.S. Food and Drug Administration advisory panel stated.
The five-point Deauville scale (5PS), used to score 18F-fluorodeoxyglucose (FDG) uptake on FDG positron emission tomography-computed tomography (PET-CT) scans, has prognostic value in follicular lymphoma.
For patients with vitiligo, a combination of afamelanotide implant and narrowband ultraviolet B (NB-UV-B) phototherapy is superior to NB-UV-B monotherapy.